A Quantitative Systems Pharmacology (QSP) Approach to Understand the Pathogenesis of Acne and to Evaluate New Acne Therapies

被引:0
|
作者
Bansal, Loveleena [1 ]
Wilde, Tom [3 ]
Gupta, Akanksha [2 ]
Kang, Grace [2 ]
Frey, Steve [2 ]
Hussey, Betty [2 ]
Damian-Iordache, Valeriu [3 ]
机构
[1] Stiefel, Discovery & Preclin Dev, Upper Merion, PA USA
[2] Stiefel, Discovery & Preclin Dev, Res Triangle Pk, NC USA
[3] GlaxoSmithKline, Modeling & Translat Biol, Upper Merion, PA USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
M-035
引用
收藏
页码:S22 / S23
页数:2
相关论文
共 50 条
  • [31] Acne vulgaris: new evidence in pathogenesis and future modalities of treatment
    Hazarika, Neirita
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (03) : 277 - 285
  • [32] Focal Acne Scar Treatment (FAST), a New Approach to Atrophic Acne Scars:A Case Series
    Schweiger, Eric S.
    Sundick, Lauren
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (10) : 1163 - 1167
  • [33] Quantitative Systems Pharmacology (QSP) modeling as a systematic approach for drug combination evaluation in Immuno-Oncology (IO)
    Kosinsky, Yuri
    Peskov, Kirill
    Voronova, Veronika
    Chu, Lulu
    Al-Huniti, Nidal
    Masson, Eric
    Helmlinger, Gabriel
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S122 - S123
  • [34] A modular approach to quantitative systems pharmacology (QSP) model development for immuno-oncology (IO) therapeutic area
    Song, Roy
    Bansal, Loveleena
    Birtwistle, Marc
    Chen, Emile
    Damian, Valeriu
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S88 - S88
  • [35] A Quantitative Systems Pharmacology (QSP) Model to Compare the Non-Clinical Biodistribution and Efficacy between Recombinant Factor IX (rIX) Therapies
    Pestel, Sabine
    Chung, Douglas
    Rezvani-Sharif, Alireza
    Muir, Ineke
    Krupa, Sivarmurthy
    Brechmann, Markus
    Verhagan, Anne
    Dower, Steve
    van der Graaf, Piet H.
    Herzog, Eva
    Ghobrial, Oliver
    BLOOD, 2021, 138
  • [36] Acne Vulgaris Topical Therapies: Application of Probiotics as a New Prevention Strategy
    Dapkevicius, Ieva
    Romualdo, Vania
    Marques, Ana Camila
    Lopes, Carla M.
    Amaral, Maria Helena
    COSMETICS, 2023, 10 (03)
  • [37] A quantitative systems pharmacology (QSP) model to compare the non-clinical biodistribution and efficacy between recombinant factor IX (rIX) therapies
    Pestel, Sabine
    Chung, Douglas
    Rezvani-Sharif, Alireza
    Muir, Ineke
    Sivamurthy, Krupa
    Brechmann, Markus
    Verhagen, Anne
    Dower, Steve
    van der Graaf, Piet
    Herzog, Eva
    Ghobrial, Oliver
    HAEMOPHILIA, 2022, 28 : 7 - 7
  • [38] New Acne Therapies and Updates on Use of Spironolactone and Isotretinoin: A Narrative Review
    Jane J. Han
    Adam Faletsky
    John S. Barbieri
    Arash Mostaghimi
    Dermatology and Therapy, 2021, 11 : 79 - 91
  • [39] New Acne Therapies and Updates on Use of Spironolactone and Isotretinoin: A Narrative Review
    Han, Jane J.
    Faletsky, Adam
    Barbieri, John S.
    Mostaghimi, Arash
    DERMATOLOGY AND THERAPY, 2021, 11 (01) : 79 - 91
  • [40] USING QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODELS TO CHARACTERIZE THE PK OF NOVEL DRUG MODALITIES
    Nobisch, Jamie
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55